MPH

ProMIS Neurosciences Announces Update to Senior Management Team

Friday, October 22, 2021 - 12:00pm

TORONTO and CAMBRIDGE, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced several updates to its senior management team.

Key Points: 
  • TORONTO and CAMBRIDGE, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced several updates to its senior management team.
  • Gavin T. Malenfant, experienced drug development executive, joins the ProMIS senior management team as Chief Operating Officer.
  • Gavin brings over 30 years of biopharmaceutical experience to the ProMIS team, with special focus on providing expert management and oversight of drug development programs.
  • Gavin will be working with the CEO and leadership of the PMN310 project team, whose key members include:
    Michael Grundman, MD, MPH, Senior Medical Adviser.

Discount Tire and TGen Partner with the American Diabetes Association

Thursday, October 21, 2021 - 4:59pm

Discount Tire and TGen are proud to be partners and supporters of the American Diabetes Association Tour de Cure.

Key Points: 
  • Discount Tire and TGen are proud to be partners and supporters of the American Diabetes Association Tour de Cure.
  • "Organizations like the ADA support causes that Discount Tire believes in promoting as a way to give back and pay it forward," said Chris Henrichsen, risk litigation officer at Discount Tire.
  • The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive.
  • Join the fight with us on Facebook (American Diabetes Association), Spanish Facebook (Asociacin Americana de la Diabetes), Twitter (@AmDiabetesAssn), and Instagram (@AmDiabetesAssn).

Adding SNAP Benefits for Older Adults in Medicare, Medicaid Can Reduce Hospital Visits, Healthcare Costs

Wednesday, October 20, 2021 - 7:25pm

Older adults facing food insecurity are more likely to have chronic health conditions like depression, asthma, diabetes, congestive heart failure and heart attack.

Key Points: 
  • Older adults facing food insecurity are more likely to have chronic health conditions like depression, asthma, diabetes, congestive heart failure and heart attack.
  • Only 48% of older adults who qualify for the Supplemental Nutrition Assistance Program (SNAP), which provides benefits to supplement budgets to purchase healthy and nutritious foods, are enrolled in the program.
  • A study published in the Annals of Internal Medicine shows the importance of older adults taking advantage of this nutrition benefit, as it is associated with fewer hospital visits and lower healthcare costs.
  • The study used a unique circumstance to better evaluate the association between SNAP participation and healthcare use and cost.

Husson University Pharmacy Students to Thank Vaccination Heroes

Wednesday, October 20, 2021 - 5:34pm

In an effort to show appreciation for their past and current service to our state, Husson University pharmacy students will be sending thank you cards to members of the Maine pharmacy community.

Key Points: 
  • In an effort to show appreciation for their past and current service to our state, Husson University pharmacy students will be sending thank you cards to members of the Maine pharmacy community.
  • The importance of the services provided by members of the pharmacy community was not lost on the students at the Husson University School of Pharmacy.
  • Husson Universitys School of Pharmacy prepares students for rewarding careers in the diverse field of pharmacy through rigorous academic coursework and hands-on practical experience.
  • The School of Pharmacy is just one of several schools that are a part of Husson Universitys College of Health and Pharmacy.

Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer

Wednesday, October 20, 2021 - 1:30pm

The safety profile of elacestrant exhibited in EMERALD was similar to that of the previous clinical trial.

Key Points: 
  • The safety profile of elacestrant exhibited in EMERALD was similar to that of the previous clinical trial.
  • Given these results, Menarini and Radius plan on proceeding with regulatory submissions in both the United States and European Union in 2022.
  • Notably, the topline results were also positive for the ESR1 mutation sub segment, an important driver of resistance to endocrine therapy in ER+/HER2- mBC patients.
  • The EMERALD Phase 3 trial is a randomized, open label, active-controlled study evaluating elacestrant as second- or third-line monotherapy in ER+/HER2- advanced/metastatic breast cancer patients.

Merck Issues Voluntary Nationwide Recall of CUBICIN® (daptomycin for injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles

Wednesday, October 20, 2021 - 12:30am

The recall has been initiated following receipt of a customer complaint reporting that a piece of glass was found in a vial of CUBICIN after reconstitution.

Key Points: 
  • The recall has been initiated following receipt of a customer complaint reporting that a piece of glass was found in a vial of CUBICIN after reconstitution.
  • Local irritation or swelling at the infusion site may occur in response to the presence of foreign material.
  • CUBICIN is packaged in single-dose, 10 mL glass vial containing 500 mg of daptomycin as a sterile, lyophilized cake, NDC 67919-011-01.
  • The affected CUBICIN lot includes the following: Bulk drug product and packaged lot 934778, expiration date June 2022.

Governmental Public Health Agencies to Partner with National Nonprofits to Build Culture of Health

Tuesday, October 19, 2021 - 3:03pm

These challenges range from a disinvestment in public health to a workforce deeply impacted by the global pandemic to the public health crisis of racism and oppression.

Key Points: 
  • These challenges range from a disinvestment in public health to a workforce deeply impacted by the global pandemic to the public health crisis of racism and oppression.
  • "Public Health at its core is governmental," according to Rene Branch Canady, PhD, MPA, chief executive officer, MPHI "This initiative leverages the capacity of public health partners to advance the vital and shared agenda of state public health leaders.
  • ASTHO members, the chief health officials of these jurisdictions, are dedicated to formulating and influencing sound public health policy and to ensuring excellence in public health practice.
  • About MPHI: MPHI is a Michigan-based, non-profit public health institute leading public health efforts across the country.

The Foundation for Dermatology Education to Host the 3rd Annual Live Revolutionizing Atopic Dermatitis (RAD) Conference - Saturday, December 11 - Monday, December 13, 2021

Tuesday, October 19, 2021 - 3:00pm

Registration is now open for this 19.5 CME and CNE credited conference - RevolutionizingAD.com .

Key Points: 
  • Registration is now open for this 19.5 CME and CNE credited conference - RevolutionizingAD.com .
  • "The Annual Live RAD Conference offers great opportunities to hear about emerging therapies and industry 'hot topics'from the best in the field."
  • New to this year's Conference, the Totally "RAD" Award recognizes a healthcare provider in the dermatology field who has provided invaluable impact to patient care or research of AD.
  • Follow the RAD Conference on the following social media sites:

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2021 Financial and Operating Results and Provides Business Update

Monday, October 18, 2021 - 9:30pm

NEWARK, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc., (NYSE: RFL), is focused on developing novel cancer metabolism therapeutics through its Barer Institute, investment in Rafael Pharmaceuticals, Inc. (“Rafael Pharmaceuticals”), a privately held, late-stage clinical oncology company focused on cancer metabolism-based therapeutics, and other early-stage companies, today reported its financial results for the three and twelve months ended July 31, 2021, and provided a business update.

Key Points: 
  • Previously, Pat wasChief Financial Officer of WindMIL Therapeutics Inc.
    On August 17, 2021, we announced the appointment of Melissa Lozner as Chief Compliance & Ethics Officer.
  • Effective September 24, 2021, the Company entered into and subsequently funded a $25.0 million Line of Credit Loan Agreement with Rafael Pharmaceuticals.
  • On August 24, 2021, we announced the closing of a private investment in public equity (PIPE) financing.
  • Our revenues for the fourth quarter of fiscal 2021 amounted to approximately $1 million, compared to revenues of approximately $1.2 million in the fourth quarter of fiscal 2020.

Mount Sinai Health System Recognized by the American Medical Association for Efforts Combating Work-Related Stress and Burnout

Monday, October 18, 2021 - 9:30pm

NEW YORK, Oct. 18, 2021 /PRNewswire-PRWeb/ --The American Medical Association (AMA) has recognized the Mount Sinai Health System as a recipient of the 2021 Joy in Medicine Health System Recognition Program for a demonstrated commitment to preserving the well-being of health care team members by engaging in proven efforts to combat work-related stress and burnout.

Key Points: 
  • NEW YORK, Oct. 18, 2021 /PRNewswire-PRWeb/ --The American Medical Association (AMA) has recognized the Mount Sinai Health System as a recipient of the 2021 Joy in Medicine Health System Recognition Program for a demonstrated commitment to preserving the well-being of health care team members by engaging in proven efforts to combat work-related stress and burnout.
  • Work-related stress and burnout were issues for health care workers well before the pandemic and have been exacerbated because of it.
  • Candidates for the Joy in Medicine Health System Recognition Program were evaluated according to their documented efforts to reduce work-related burnout through system level drivers.
  • The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region.